This large national cohort study highlights a significant gap in stroke prevention for patients with incident non-valvular atrial fibrillation, demonstrating low rates of persistent warfarin use and suboptimal time in therapeutic range.
No takes yet. Share an insight, caveat, or question.
Highlights gaps in real-world AF anticoagulation; leaves open optimal strategies to improve persistence and outcomes.
Haim et al. (2015) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: